![[When mechanical ventilation fails-Venovenous extracorporeal membrane oxygenation].](https://www.covidnewscast.com/wp-content/uploads/2023/09/References.png "[When mechanical ventilation fails-Venovenous extracorporeal membrane oxygenation].")
Publication date: Sep 18, 2023
Venovenous extracorporeal membrane oxygenation (VV-ECMO) is predominantly being used as a rescue strategy in patients with acute lung failure, suffering from severe oxygenation and/or decarboxylation impairment. Cannulas introduced into the central veins lead blood through a membrane oxygenator in which it is oxygenated via sweep gas (pO up to 600 mm Hg) flow, eliminating CO. According to the largest randomized studies carried out so far, the two most important indications for VV-ECMO are hypoxic respiratory failure (paO2 30/min) despite optimal protective mechanical ventilation settings (ARDS, Δp
| Concepts | Keywords |
|---|---|
| 600mmhg | Bridge to transplant |
| Decarboxylation | Coronavirus disease 2019 (COVID-19) |
| Oxygenator | Respiratory insufficiency |
| Pao230 | |
| Severe |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | IDO | blood |
| disease | MESH | respiratory failure |
| disease | MESH | Acute respiratory distress syndrome |
| disease | MESH | Coronavirus disease 2019 |
| disease | IDO | quality |
Original Article
(Visited 1 times, 1 visits today)